| Project/Area Number |
25460621
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Medical sociology
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2015: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
|
|---|
| Keywords | 研究倫理 / 国際情報交換 / 臨床試験 / 早期探索的臨床試験 / 被験者保護 / 倫理審査委員会 / 健康人ボランティア / 医学哲学 |
|---|
| Outline of Final Research Achievements |
We all enjoy the benefits of medical drugs. However, the results of my survey show that half of the general public has not thought over the fact that healthy volunteers participate in clinical trials. Some, although a minority, show ethical concerns about the implementation of first in man clinical trials and the process of approval. Most healthy volunteers think that they are participating in first in man clinical trials for remuneration, but some participate for the medical contribution and for helping patients. Cancer patients and their family think that cancer patients participate in first in man clinical trials for their treatment, and to help future patients. The results indicate that altruism may be shown in first in man clinical trials. Now, innovation of the development of new drugs is one of the national policies. We are asked to reconsider these issues presented here in realistic medical research fronts.
|
